Aleve Tablet
NDC Package 0280-6000-08
Package Information
Aleve (naproxen sodium) tablets is naproxen is used to relieve pain from various conditions. This formulation utilizes a tablet delivery system. Marketed by Bayer Healthcare Llc., this product is identified by NDC 0280-6000 and is authorized under FDA application NDA020204.
Identification & Billing
- RxCUI: 849574 - naproxen sodium 220 MG Oral Tablet
- RxCUI: 849574 - naproxen sodium 220 MG (as naproxen 200 MG) Oral Tablet
- RxCUI: 849728 - Aleve 220 MG Oral Tablet
- RxCUI: 849728 - naproxen sodium 220 MG Oral Tablet [Aleve]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0280 - Bayer Healthcare Llc.
- 0280-6000 - Aleve
- 0280-6000-08 - 1 BOTTLE in 1 CARTON / 65 TABLET in 1 BOTTLE
- 0280-6000 - Aleve
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0280-6000). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0280-6000-08 identifies a specific commercial package of 1 bottle in 1 carton / 65 tablet in 1 bottle of Aleve Caplets, a human over the counter drug labeled by Bayer Healthcare Llc.. This tablet is formulated for oral use and contains naproxen sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bayer Healthcare Llc. on February 26, 2014. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Naproxen is used to relieve pain from various conditions. It also reduces pain, swelling, and joint stiffness caused by arthritis, bursitis, and gout attacks. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. Some brands of sustained-release naproxen take longer to be absorbed and are not recommended for pain that needs quick relief (such as during a gout attack). Ask your doctor or pharmacist if you have questions about your particular brand.
How is this Bayer Healthcare Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00280600008. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.
